JY

James L. Yeager

CTO & VP, Formulation Development at Achelios Therapeutics

Jim is a pharmaceutical scientist who has actively developed new drug delivery technologies and new drug products for 30 years. He is an author, inventor, and expert in the field of topical drug delivery. Most recently, his research led to the development of new, innovative topical products for wound healing and the treatment of male and female sexual dysfunction, fungal and viral infections, and peripheral pain. Jim has an undergraduate degree in Pharmacy and a Ph.D. in industrial and Physical Pharmacy from Purdue University.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Achelios Therapeutics

Achelios Therapeutics’ lead reformulation product, TOPOFEN™, pairs its proprietary ACHETOGEL™ delivery technology with the proven NSAID ketoprofen. In pre-clinical and early-stage clinical studies, they have shown TOPOFEN™ (ketoprofen) to provide superior tissue penetration compared to other topical formulations currently on the market.


Industries

Employees

1-10

Links